Sign In
Buy MRK
$115.17
+0.270 (+0.235%)
At Close: Jun 16, 2026
MRK, Daiichi's ADC Drug Gets FDA Breakthrough Tag for Ovarian Cancer
12:21pm, Tuesday, 16'th Sep 2025
Merck and Daiichi's raludotatug deruxtecan wins FDA Breakthrough tag for treating CDH6 expressing platinum-resistant ovarian, primary peritoneal or fallopian tube cancers.
Is Merck (MRK) a Buy as Wall Street Analysts Look Optimistic?
10:31am, Tuesday, 16'th Sep 2025
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analy
2 Healthcare Dividend Stocks to Buy and Hold
07:15am, Sunday, 14'th Sep 2025
Between labor-market data and potential interest-rate cuts, Wall Street has a lot on its plate right now. In an environment like this one, it can be helpful to invest in solid, dividend-paying stocks
Merck Falls 14% YTD: Time to Buy, Sell or Hold the Stock?
11:05am, Thursday, 11'th Sep 2025
Merck stock is down 14% this year as Keytruda-led growth gets offset by Gardasil weakness and looming patent risks, which cloud the outlook.
Merck's pneumonia shot shows promise in late-stage study
06:55am, Thursday, 11'th Sep 2025
Drugmaker Merck said on Thursday that its pneumonia shot showed strong immune responses in children and teens who are at higher risk of serious illness, based on results from a late-stage study presen
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--CAPVAXIVE Demonstrates Positive Immune Responses in Children and Adolescents at Increased Risk of Pneumococcal Disease.
Britain defends investment record as Merck scraps labs over pharma environment
05:43am, Thursday, 11'th Sep 2025
Britain defended its record on attracting investment on Thursday after U.S. drugmaker Merck said it was abandoning a new London research centre and a top industry lobby group warned a challenging busi
Merck axes £1bn London lab in blow to UK life sciences
03:17am, Thursday, 11'th Sep 2025
Britain's ambition to become a global science powerhouse has suffered a major setback after Merck, known in Europe as MSD, abandoned plans for a £1 billion research hub in London. About 125 scientist
Merck to scrap London drug research centre
12:15pm, Wednesday, 10'th Sep 2025
Merck said on Wednesday it was scrapping research operations in London, citing the UK's challenging business environment.
US FDA to step up enforcement of pharma ads, sends enforcement letters
07:12pm, Tuesday, 09'th Sep 2025
The U.S. Food and Drug Administration will send out around 100 cease-and-desist enforcement notices and thousands of letters warning pharmaceutical companies that direct-to-consumer ads must comply wi
Will Merck's Cost Cuts and New Drug Approvals Ease Headwinds?
09:51am, Tuesday, 09'th Sep 2025
MRK expects strong Keytruda sales, new drug launches and $3B in planned cost savings to offset pressure from declining Gardasil sales and other headwinds.
Merck & Co., Inc. (MRK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
05:16pm, Monday, 08'th Sep 2025
Merck & Co., Inc. (NYSE:MRK ) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 2:35 PM EDT Company Participants Robert Davis - Chairman, President & CEO Eliav Barr - Chief Med
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)
08:05am, Saturday, 06'th Sep 2025
5 Relatively Secure And Cheap Dividend Stocks, Yields Up To 9% (Sept. 2025)
September Dogs Of The Dow Unleash One Ideal 'Safer' DiviDog
02:07am, Saturday, 06'th Sep 2025
Verizon stands out as the only Dow stock meeting the 'dogcatcher' ideal: annual dividends from $1K invested exceed its share price and are well-covered. Analyst forecasts suggest top Dow Dogs could de
Merck & Co., Inc. (MRK) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
02:30pm, Thursday, 04'th Sep 2025
Merck & Co., Inc. (NYSE:MRK ) Wells Fargo 20th Annual Healthcare Conference 2025 September 4, 2025 11:50 AM EDT Company Participants Eliav Barr - Chief Medical Officer & Head of Global Clinical Develo
